Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
CA 2430716 A1 · Owner: Dean, Michael · Inventors: Dean, Michael; Rosier-Montus, Marie-Francoise; Arnould-Reguigne, Isabelle
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to nucleic acids corresponding to various exons of ABCA5, ABCA6, ABCA9, and ABCA10 genes as well as cDNAs encoding the novel full length of ABCA5, ABCA6, ABCA9, and ABCA10 proteins. The invention also relates to means for the detection of polymorphisms in general and of , mutations in particular, in the ABCA5 ABCA6, ABCA9, and ABCA10 genes or in , the corresponding protein produced by the allelic form of the ABCA5 ABCA6, ABCA9, and ABCA10 genes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 7, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 7, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 7, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.